Navigation Links
Protocol for RNA Isolation Using TRIzol Reagent with Phase Lock ,,, Gel-Heavy

Phase Lock Gel may be used in conjunction with TRIzol Reagent for the isolation of total RNA from cell and tissue samples. Increased yields are observed using this method, because the entire aqueous phase can be recovered without interphase contamination. Below is a protocol outlining the steps involved in RNA isolation with TRIzol Reagent and Phase Lock Gel-Heavy. For further details about TRIzol Reagent, please refer to TRIzol Reagent protocol.

IMPORTANT: When working with TRIzol Reagent, use appropriate protective clothing and work under a chemical fume hood.

  1. Homogenization:
    1. Tissues: Add 1 ml TRIzol Reagent per 50100 mg tissue and homogenize with a POLYTRON homogenizer. For 110 mg quantities of tissue, add 0.8 ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
    2. Cells grown in a Monolayer: Lyse cells by adding 1 ml TRIzol Reagent per 10 cm2 area of culture dish. Pipette suspension several times to disrupt cells. For 102104 cells, add 0.8 ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
    3. Cells grown in Suspension: Pellet cells by centrifugation. Do not wash cell pellet. Add 1 ml TRIzol Reagent per 510 x 106 animal, plant, or yeast cells or 1 x 107 bacterial cells. Resuspend pellet by pipetting to lyse cells. For 102104 cells, add 0.8 ml TRIzol Reagent and 0.2 ml 1 mg/ml mussel glycogen and homogenize.
  2. Pre-spin the appropriate sized Phase Lock Gel-Heavy tubes briefly to collect gel on tube bottoms (1500 x g for 30 seconds is sufficient to collect gel at tube bottoms).
  3. Add cell lysate to the tubes containing pre-spun Phase Lock Gel-Heavy and incubate 5 minutes at 1530C.
  4. Add 0.2 ml chloroform (or chloroform-isoamyl alcohol) per 1 ml TRIzol Reagent initially used. Cap tubes and shake vigorously for 15 seconds. DO NOT VORTEX!
  5. Centrifuge samples at no more than 12,000 x g for 10 minutes at 28C.
    NOTE: 15 ml and 50 ml PLG-H screw-cap tubes should be centrifuged at or below 2000 x g.
  6. Examine phasing. Clear, aqueous phase should be entirely atop Phase Lock Gel. The phenol-chloroform phase and cloudy interphase should be below Phase Lock Gel layer. If this is not the case, add another 0.2 ml chloroform (or chloroform-isoamyl alcohol) per 1 ml TRIzol Reagent used initally and shake vigorously. Repeat centrifugation and re-examine phasing.
  7. Transfer aqueous phase containing RNA to a fresh tube (aqueous phase may be decanted).
  8. Precipitate RNA by adding 0.5 ml Isopropyl alcohol per 1 ml TRIzol Reagent used initially. Mix samples by repeated inversion. Allow samples to incubate at 1530C for 10 minutes. Centrifuge samples for 10 minutes at no more than 12,000 x g, 28C. RNA pellet should be visible on side and bottom of tube.
  9. Decant supernatant. Add 1 ml 75% ethanol per 1 ml TRIzol Reagent used initially to wash the RNA pellet. Mix samples to dislodge pellet, using a vortex if necessary. Centrifuge samples at no more than 7,500 x g for 5 minutes at 28C.
  10. Carefully decant supernatant. Briefly air-dry or vacuum-dry the RNA pellet to remove residual ethanol (510 minutes). Do not overdry pellet by centrifugation under vacuum as this will make resuspension more difficult. Dissolve RNA pellet in Molecular Biology Grade water, incubating at 5560C for 10 minutes to facilitate dissolution.


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. New Protocols for Isolating High- Molecular-Weight Genomic DNA
2. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
3. Lambda DNA Extraction Protocol
4. M13/Phagemid DNA Extraction Protocol
5. Mouse Tail Genomic DNA Isolation Protocol(1)
6. Genomic DNA Isolation Protocol(1,2,3)
7. Basic Plasmid DNA Isolation Protocol
8. RNA-free Plasmid DNA Isolation Protocol
9. Lambda DNA Extraction Protocol
10. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
11. M13/Phagemid DNA Extraction Protocol
Post Your Comments:
(Date:7/30/2014)... (PRWEB) July 30, 2014 With ... increase of personal health expenditure as well as ... care system, China diagnostic reagent industry has been ... over 90%. In 2013, Chinese in vitro diagnostics ... billion came from in vitro diagnostic reagents. ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Yuma ... facility and complementary therapies brings comprehensive cancer care ... state-of-the-art Yuma Regional Cancer Center has officially opened. ... the program includes services such as open, semi-private ... therapy, American Cancer Society Resource Center, hematology, rehabilitation ...
(Date:7/30/2014)... , July 30, 2014   Epic Sciences, Inc. ... develops novel diagnostics to personalize and advance the treatment ... Gregory T. Lucier as chairman of Epic,s ... CEO of Life Technologies (formerly Invitrogen). Mr. Lucier joins ... commercializes its circulating rare cell analysis platform with special ...
(Date:7/30/2014)... July 30, 2014 Connecticut Center for ... based in East Hartford, Conn., was awarded a Rural ... of a project that will determine the feasibility of ... north-central Connecticut. USDA Rural Development provided $53,000 for CCAT ... the second phase of the feasibility study in fiscal ...
Breaking Biology Technology:China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 2Epic Sciences Appoints Greg Lucier as Chairman of the Board of Directors 3USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 2USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 3
... PRINCETON, N.J., TOKYO, and REDWOOD CITY, Calif., March ... Inc. (Nasdaq: PDLI ) today announced the ... has acquired PDL,s,rights to IV Busulfex(R) (busulfan), including ... million plus inventory,value., IV Busulfex is an ...
... Calif., March 10 Cepheid (Nasdaq:,CPHD) will present ... March 18 at 10:15 a.m. ET at The ... Chief Executive Officer, will provide a corporate overview., ... may be,accessed on Cepheid,s Web site at ...
... late 2007 ... ... prescribing information for PROCRIT(R) (Epoetin alfa),following guidance from the U.S. Food and ... class., Modifications to the label were based on an unplanned interim ...
Cached Biology Technology:Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex 2Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex 3Otsuka Pharmaceutical and PDL BioPharma Close Sale of IV Busulfex 4Cepheid to Present at Cowen and Company's 28th Annual Healthcare Conference 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 2Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 3Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 4Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 5Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 6Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa) 7
(Date:7/30/2014)... better decisions about what they eat, the Food and ... to the Nutrition Facts label found on nearly every ... Chemical & Engineering News (C&EN), the weekly news ... updates and the fight that has ensued. , ... that while the Nutrition Facts label has remained largely ...
(Date:7/30/2014)... is a subject of major interest in neuroscience. ... during the distinct stages of Wallerian degeneration: transcription ... dedifferentiation. Although gene expression responses in the distal ... injury are known, differences in gene expression between ... Dengbing Yao and co-workers from Nantong University, China ...
(Date:7/30/2014)... JOSE, Calif. , July 30, 2014 /PRNewswire/ ... partnership with the United States Air Force Research ... proposed by Binghamton University ... human performance monitoring (HPM). The $425,000 project, with ... electronics packaging firm i3 Electronics, Inc. ( ...
Breaking Biology News(10 mins):Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 2Nano-Bio Manufacturing Consortium Awards Funding to Binghamton University for Development of Electronics and Biometric Sensor Platforms 3
... could see humble cotton thread emerge as a core ... such as kidney failure and diabetes. In a ... and sewing needles to literally stitch,together the uniquely low-cost ... postage stamp. Microfluidic analytical devices, which have been ...
... University of Wisconsin-Madison engineers has developed a highly ... a biomass derivative, into the chemical equivalent of ... 95 percent of the energy from the original ... dioxide under high pressure for future beneficial use. ...
... new University of Colorado at Boulder study shows mice ... with a deadly and poorly understood human inflammatory disease, ... The human disease, known as Hemophagocytic Lymphohistiocytosis, or HLH, ... percent and 90 percent of its victims, said Diane ...
Cached Biology News:How long is a piece of thread? Long enough to save a life 2New process yields high-energy-density, plant-based transportation fuel 2New University of Colorado paper shows novel way to study human inflammatory disease 2
... pLivSelect is a ... for recombinant identification. Recombinant ... colony survival, eliminating the ... screening. This quick and ...
... Signal Enhancer does for enzyme-/substrate-based blotting what intensifying ... the signal up to 10-fold (or one order ... Western Blot Signal Enhancer membrane treatment is a ... to your current Western blotting protocol. The result ...
... multi-functional program that searches for ... sequence file for polymerase chain ... mutagenesis, and various hybridization applications. ... secondary structure of oligonucleotides based ...
...
Biology Products: